<DOC>
	<DOCNO>NCT02613195</DOCNO>
	<brief_summary>The purpose study investigate whether hydrogen-rich Celsior solution improve quality age graft liver/kidney transplantation .</brief_summary>
	<brief_title>Clinical Trial Hydrogen-Rich Celsior Solution Applied Aging DBD Liver/Kidney Transplantation</brief_title>
	<detailed_description>The organ shortage rise impede development organ transplantation.To find solution , transplantation center work application marginal graft liver renal , especially age graft . The common inducement organ dysfunction perioperation liver/renal ischemia-reperfusion ( I/R ) injury , cause generation cytotoxic oxygen radical . Hydrogen gas kind reduce gas , report display antioxidant property protective effect organ dysfunction induce various I/R injury . Investigators investigate whether hydrogen-rich Celsior solution improve quality age graft liver/ kidney transplantation .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Donors : 1 . Age donor ≥60 yr . 2 . The donor historical record drug abuse , alcoholic abuse , homosexual , drug addiction , etc . 3 . Evaluate infection infectious disease donor . 4 . History malignant tumor ; 5 . History hypertension , diabetes , hemophilia , anticoagulant disease , kidney donor history kidney disease . 6 . Daily urine volume approximately normal . 7 . Donor subject physical examination medical doctor OPO stuff donation ; OPO stuff realize whether potential donor infect lesion , abscess , ulcer , lymphadenectasis， etc. , evaluate infectious risk recipient postoperationally . 8 . OPO stuff realize dynamic change body temperature , well various intensive care parameter potential donor , shall important sure whether potential donor pulmonary/ systemic infection , especially longer ICU duration ( &gt; 7 Days ) . 9 . The potential donor systolic blood pressure ≥ 50 mm Hg ( 1mmHg=0.133 kPa ) arterial SaO &gt; 80 % . 10 . Liver Biochemistry : alanine aminotransferase ( ALT ) ≤ 6ULN , total bilirubin ( TBil ) ≤ 50umol/L ; Kidney Biochemistry : serum creatinine ( sCre ) ≤ 2ULN ; 11 . Negative antiHIV antibody ; 12 . Negative bacterial fungal culture blood ; 13 . Ultrasonic diagnosis fatty liver , trauma , hematoma , lithiasis , etc. , well size kidney , hydronephrosis , nephrolithiasis , etc . possible . 14 . Graft liver soft , normal color even , tumor abnormity ; steatosis ≤ 30 % liver biopsy.Graft kidneys complete renal capsule congestion bleeding ; proximal tubular necrosis ≤ 50 % , without obvious structural damage.Organ ( liver kidney ) cold ischemia time ( CIT ) determine time duration cold preservation organ transplant reperfusion . CIT age DBD liver kidney graft ≤ 10 and16 hour , respectively . Recipients： 1 . Aged 1865 year old 2 . MELD score ≤25 , BMI≤25 3 . Patients tumor , expect lifetime≥6 month 4 . Agree anticipate trial sign inform consent Donor 's age ＜ 60 yr ; The donor historical record drug abuse , alcoholic abuse , homosexual , drug addiction , etc . The donor HIV infect , severe infection , positive bacterial and/ fungal culture result ; Uncontrollable hypertension , diabetic ; Malignant tumor ; Unstable hemodynamic response SaO status , systolic pressure ＜50 mm Hg ( 1mmHg=0.133 kPa ) , arterial SaO＜80 % . Liver Biochemistry : alanine aminotransferase ( ALT ) ＞6ULN , total bilirubin ( TBil ) ＞50umol/L ; Graft liver steatosis ＞30 % , graft kidney proximal tubular necrosis＞50 % obvious glomerular sclerosis .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Ischemia-Reperfusion Injury</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>organ preservation</keyword>
	<keyword>Hydrogen</keyword>
	<keyword>Kidney Transplantation</keyword>
</DOC>